{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Liposomes : Questions médicales les plus fréquentes",
"headline": "Liposomes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Liposomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-01",
"dateModified": "2025-04-26",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Liposomes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Membrane artificielle",
"url": "https://questionsmedicales.fr/mesh/D008567",
"about": {
"@type": "MedicalCondition",
"name": "Membrane artificielle",
"code": {
"@type": "MedicalCode",
"code": "D008567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.087.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Liposomes unilamellaires",
"alternateName": "Unilamellar Liposomes",
"url": "https://questionsmedicales.fr/mesh/D053835",
"about": {
"@type": "MedicalCondition",
"name": "Liposomes unilamellaires",
"code": {
"@type": "MedicalCode",
"code": "D053835",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.087.500.517.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Liposomes",
"alternateName": "Liposomes",
"code": {
"@type": "MedicalCode",
"code": "D008081",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mahmoud Reza Jaafari",
"url": "https://questionsmedicales.fr/author/Mahmoud%20Reza%20Jaafari",
"affiliation": {
"@type": "Organization",
"name": "Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."
}
},
{
"@type": "Person",
"name": "Yongyi Zeng",
"url": "https://questionsmedicales.fr/author/Yongyi%20Zeng",
"affiliation": {
"@type": "Organization",
"name": "The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Xiaolong Liu",
"url": "https://questionsmedicales.fr/author/Xiaolong%20Liu",
"affiliation": {
"@type": "Organization",
"name": "The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350025, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Dianping Tang",
"url": "https://questionsmedicales.fr/author/Dianping%20Tang",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Analytical Science for Food Safety and Biology (MOE & Fujian Province), Department of Chemistry, Fuzhou University, Fuzhou 350108, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Thomas Lars Andresen",
"url": "https://questionsmedicales.fr/author/Thomas%20Lars%20Andresen",
"affiliation": {
"@type": "Organization",
"name": "Center for Nanomedicine and Theranostics, Center for Intestinal Absorption and Transport of Biopharmaceuticals, Department of Health Technology, Technical University of Denmark, DK-2800, Kgs. Lyngby, Denmark."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "RASCL: Rapid Assessment of Selection in CLades through molecular sequence analysis.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36322581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0275623"
}
},
{
"@type": "ScholarlyArticle",
"name": "Large-Scale Whole Genome Sequence Analysis of >22,000 Subjects Provides no Evidence of",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37628570",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes14081518"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162726",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11011-023-01221-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "SeqWiz: a modularized toolkit for next-generation protein sequence database management and analysis.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37194023",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12859-023-05334-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of two approaches in multichannel sequence analysis using the Swiss Household Panel.",
"datePublished": "2022-12-20",
"url": "https://questionsmedicales.fr/article/37874200",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1332/175795921X16698302233894"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Matériaux biomimétiques",
"item": "https://questionsmedicales.fr/mesh/D040761"
},
{
"@type": "ListItem",
"position": 5,
"name": "Membrane artificielle",
"item": "https://questionsmedicales.fr/mesh/D008567"
},
{
"@type": "ListItem",
"position": 6,
"name": "Liposomes",
"item": "https://questionsmedicales.fr/mesh/D008081"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Liposomes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Liposomes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Liposomes",
"description": "Comment identifier un liposome dans un échantillon?\nQuels tests sont utilisés pour analyser les liposomes?\nLes liposomes peuvent-ils être visualisés par IRM?\nQuelle méthode évalue la taille des liposomes?\nPeut-on détecter des liposomes dans le sang?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Liposomes",
"description": "Quels effets secondaires peuvent être causés par des liposomes?\nLes liposomes provoquent-ils des douleurs au site d'injection?\nLes liposomes peuvent-ils causer des nausées?\nY a-t-il des symptômes d'intolérance aux liposomes?\nLes liposomes affectent-ils le système immunitaire?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Liposomes",
"description": "Les liposomes peuvent-ils prévenir des maladies?\nComment les liposomes aident-ils à la prévention des infections?\nLes liposomes sont-ils utilisés dans des traitements préventifs?\nPeut-on utiliser des liposomes pour la prévention du cancer?\nLes liposomes peuvent-ils être utilisés en prophylaxie?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Liposomes",
"description": "Comment les liposomes sont-ils utilisés en chimiothérapie?\nLes liposomes sont-ils utilisés pour vaccins?\nQuels médicaments sont souvent encapsulés dans des liposomes?\nLes liposomes peuvent-ils améliorer la biodisponibilité des médicaments?\nComment les liposomes ciblent-ils les tissus malades?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Liposomes",
"description": "Quelles complications peuvent survenir avec les liposomes?\nLes liposomes peuvent-ils causer des effets indésirables graves?\nComment gérer les complications liées aux liposomes?\nLes liposomes peuvent-ils interagir avec d'autres médicaments?\nY a-t-il des risques d'infection avec les liposomes?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Liposomes",
"description": "Quels facteurs augmentent les risques liés aux liposomes?\nLes personnes âgées sont-elles à risque avec les liposomes?\nLes patients immunodéprimés sont-ils plus à risque?\nLes allergies alimentaires influencent-elles l'utilisation des liposomes?\nLes interactions médicamenteuses sont-elles un facteur de risque?",
"url": "https://questionsmedicales.fr/mesh/D008081?mesh_terms=Sequence+Analysis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un liposome dans un échantillon?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent être identifiés par microscopie électronique ou par techniques de diffusion."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour analyser les liposomes?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la chromatographie et la spectroscopie sont utilisés pour analyser les liposomes."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils être visualisés par IRM?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les liposomes peuvent être marqués et visualisés par IRM pour des études d'imagerie."
}
},
{
"@type": "Question",
"name": "Quelle méthode évalue la taille des liposomes?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La diffusion dynamique de la lumière est couramment utilisée pour évaluer la taille des liposomes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des liposomes dans le sang?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques comme la cytométrie en flux peuvent détecter des liposomes dans le sang."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent être causés par des liposomes?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent provoquer des réactions allergiques ou des irritations au site d'injection."
}
},
{
"@type": "Question",
"name": "Les liposomes provoquent-ils des douleurs au site d'injection?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs ou des rougeurs peuvent survenir au site d'injection des liposomes."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils causer des nausées?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées peuvent survenir, mais elles sont généralement liées au médicament encapsulé, pas aux liposomes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes d'intolérance aux liposomes?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes d'intolérance peuvent inclure des démangeaisons ou des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les liposomes affectent-ils le système immunitaire?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent moduler la réponse immunitaire, mais les effets varient selon la formulation."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils prévenir des maladies?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent être utilisés pour délivrer des vaccins, aidant à prévenir certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment les liposomes aident-ils à la prévention des infections?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent encapsuler des antibiotiques pour cibler et prévenir les infections localisées."
}
},
{
"@type": "Question",
"name": "Les liposomes sont-ils utilisés dans des traitements préventifs?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont utilisés dans des traitements préventifs, notamment pour des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des liposomes pour la prévention du cancer?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des liposomes sont en recherche pour délivrer des agents préventifs contre le cancer."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils être utilisés en prophylaxie?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés pour la prophylaxie, notamment dans les traitements antiviraux."
}
},
{
"@type": "Question",
"name": "Comment les liposomes sont-ils utilisés en chimiothérapie?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes encapsulent des médicaments anticancéreux pour cibler les cellules tumorales et réduire les effets secondaires."
}
},
{
"@type": "Question",
"name": "Les liposomes sont-ils utilisés pour vaccins?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les liposomes servent de vecteurs pour des vaccins, améliorant la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont souvent encapsulés dans des liposomes?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'adrénomycine et la doxorubicine sont souvent encapsulés dans des liposomes."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils améliorer la biodisponibilité des médicaments?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les liposomes augmentent la biodisponibilité des médicaments en facilitant leur absorption."
}
},
{
"@type": "Question",
"name": "Comment les liposomes ciblent-ils les tissus malades?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les liposomes peuvent être modifiés pour cibler spécifiquement les tissus malades grâce à des ligands."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les liposomes?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions allergiques, des infections ou des inflammations au site d'injection."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils causer des effets indésirables graves?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que rares, des effets indésirables graves comme des chocs anaphylactiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux liposomes?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications implique l'arrêt du traitement et le traitement des symptômes associés."
}
},
{
"@type": "Question",
"name": "Les liposomes peuvent-ils interagir avec d'autres médicaments?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les liposomes peuvent interagir avec d'autres médicaments, affectant leur efficacité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques d'infection avec les liposomes?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques d'infection peuvent survenir, surtout si les liposomes sont administrés par injection."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les risques liés aux liposomes?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies et les maladies auto-immunes peuvent augmenter les risques liés aux liposomes."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque avec les liposomes?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires avec les liposomes."
}
},
{
"@type": "Question",
"name": "Les patients immunodéprimés sont-ils plus à risque?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés peuvent avoir un risque accru de complications avec les liposomes."
}
},
{
"@type": "Question",
"name": "Les allergies alimentaires influencent-elles l'utilisation des liposomes?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des allergies alimentaires peuvent influencer la tolérance aux liposomes et leurs formulations."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les interactions médicamenteuses peuvent augmenter les risques d'effets indésirables des liposomes."
}
}
]
}
]
}
An important unmet need revealed by the COVID-19 pandemic is the near-real-time identification of potentially fitness-altering mutations within rapidly growing SARS-CoV-2 lineages. Although powerful m...
Alzheimer disease (AD) is a leading cause of dementia in elderly patients who continue to live between 3 and 11 years of diagnosis. A steep rise in AD incidents is observed in the elderly population i...
Current proteomic technologies are fast-evolving to uncover the complex features of sequence processes, variations and modifications. Thus, protein sequence database and the corresponding softwares sh...
We developed a state-of-the-art toolkit (SeqWiz) for constructing next-generation sequence databases and performing proteomic-centric sequence analyses. First, we proposed two derived data formats: SQ...
SeqWiz is designed to be a collection of modularized tools, which is friendly to both end-users for preparing easy-to-use sequence databases as well as bioinformaticians for performing downstream sequ...
Sequence analysis is an established approach to study life courses. When several life domains are considered simultaneously, multichannel sequence analysis (MSA) and the extended alphabet (EA) approac...
A novel lytic Ralstonia phage, RPZH3, was isolated from the soil of a tobacco field via a double agar overlay plaque assay. The phage has an icosahedral head 75 ± 5 nm in diameter with a short tail ab...
The RPMS1 gene is the only member of the BamHI-A rightward transcripts (BARTs) family for which a full-length complementary DNA has been identified, and RPMS1 transcript has been confirmed in many Eps...
Trypanosoma cruzi is an obligate parasite that uses glucose as one of the main resources to maintain its survival and proliferation. In eukaryotic cells glucose transport across membranes is mediated ...
The knowledge about the long-term consequences in terms of sickness absence (SA) among pedestrians injured in a traffic-related accident, including falls, is scarce. Therefore, the aim was to explore ...
A nationwide register-based study, including all individuals aged 20-59 and living in Sweden, who in 2014-2016 had in- or specialized outpatient healthcare after a new traffic-related accident as a pe...
In total, 11,432 pedestrians received healthcare due to a traffic-related accident. Eight clusters of SA patterns were identified. The largest cluster was characterized by no SA, three clusters had di...
This nationwide study of the working-aged pedestrians observed diverging patterns of SA after their accident. The largest cluster of pedestrians had no SA, and the other seven clusters had different p...
Carbapenems are among the few effective antibiotics against multidrug-resistant Enterobacteriaceae. This study aimed at characterizing the plasmid content and resistome of clinical carbapenem-resistan...
Plasmid typing and whole-genome sequencing were used to study the genomic characteristics of 65 clinical CREs including 27 Escherichia coli, 24 Klebsiella pneumoniae, one Klebsiella quasipneumoniae, t...
bla...
We analysed the clonality and resistance determinants of 65 multidrug-resistant (MDR) Enterobacteriaceae recovered in the period from 2016 to 2019 from a large tertiary hospital in Lebanon. NDM varian...